Latest News about Biotech
Recent news which mentions Biotech
Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
April 08, 2024
From Benzinga
Bristol Myers Squibb's Acquired Adagrasib Combo Therapy May Benefit Colorectal Cancer Patients With Certain Mutation
April 08, 2024
From Benzinga
AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor
April 08, 2024
From Benzinga
From Benzinga
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease
April 08, 2024
From Benzinga
Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data
April 08, 2024
From Benzinga
Luminis Water Tech Optimises Water and Shrimp Gut Microbiomes, Achieves 56% Gain in Growth - 30% Reduction in Pathogens
April 08, 2024
From Issuewire
President Biden's Campaign Hits Historic $90M Fundraising In March, Trump Left In Financial Dust
April 06, 2024
Tickers
NEWS
From Benzinga
Moderna's Vaccines Day 2024: A Glimpse into the Future of Infectious Disease Prevention
April 05, 2024
Tickers
MRNA
From Benzinga
From Benzinga
Pfizer's Paxlovid Demonstrates Safety But Raises Questions on Efficacy in Low-Risk Covid-19 Patients-NEJM Study
April 05, 2024
From Benzinga
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
April 05, 2024
From Benzinga
New Hope for Aggressive Lung Cancer: AstraZeneca's Imfinzi Shows Promising Results in Phase 3 Trial
April 05, 2024
From Benzinga
What's Going On With Candel Therapeutics Stock On Friday?
April 05, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.